Y a-t-il un risque accru de récidive après traitement ?
Oui, le risque de récidive est élevé, nécessitant un suivi régulier après traitement.
RécidiveSuivi médicalCarcinome corticosurrénalien
#5
Le carcinome corticosurrénalien peut-il affecter la qualité de vie ?
Oui, les symptômes et les traitements peuvent significativement impacter la qualité de vie.
Qualité de vieSymptômesCarcinome corticosurrénalien
Facteurs de risque
5
#1
Quels sont les principaux facteurs de risque du carcinome corticosurrénalien ?
Les antécédents familiaux, certaines maladies génétiques et l'obésité sont des facteurs de risque.
Facteurs de risqueObésitéCarcinome corticosurrénalien
#2
Les maladies génétiques augmentent-elles le risque ?
Oui, des syndromes comme le syndrome de Li-Fraumeni augmentent le risque de ce cancer.
Syndrome de Li-FraumeniGénétiqueCarcinome corticosurrénalien
#3
L'âge est-il un facteur de risque ?
Oui, le carcinome corticosurrénalien est plus fréquent chez les adultes jeunes à moyens.
ÂgeCarcinome corticosurrénalienFacteurs de risque
#4
Le sexe influence-t-il le risque de ce cancer ?
Les femmes sont légèrement plus susceptibles de développer ce cancer que les hommes.
SexeCarcinome corticosurrénalienFacteurs de risque
#5
Le stress a-t-il un impact sur le risque de carcinome ?
Bien que le stress soit un facteur de santé, son lien direct avec ce cancer n'est pas établi.
StressSantéCarcinome corticosurrénalien
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Carcinome corticosurrénalien : Questions médicales les plus fréquentes",
"headline": "Carcinome corticosurrénalien : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Carcinome corticosurrénalien : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-07-04",
"dateModified": "2025-03-31",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Carcinome corticosurrénalien"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Tumeurs corticosurrénaliennes",
"url": "https://questionsmedicales.fr/mesh/D000306",
"about": {
"@type": "MedicalCondition",
"name": "Tumeurs corticosurrénaliennes",
"code": {
"@type": "MedicalCode",
"code": "D000306",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C19.344.078.265"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Carcinome corticosurrénalien",
"alternateName": "Adrenocortical Carcinoma",
"code": {
"@type": "MedicalCode",
"code": "D018268",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Martin Fassnacht",
"url": "https://questionsmedicales.fr/author/Martin%20Fassnacht",
"affiliation": {
"@type": "Organization",
"name": "Division of Endocrinology and Diabetes, Department of Internal Medicine I, University Hospital, University of Würzburg, Würzburg, Germany; Comprehensive Cancer Mainfranken, University of Würzburg, Würzburg, Germany; Central Laboratory, University Hospital Würzburg, Würzburg, Germany."
}
},
{
"@type": "Person",
"name": "Constanze Hantel",
"url": "https://questionsmedicales.fr/author/Constanze%20Hantel",
"affiliation": {
"@type": "Organization",
"name": "Klinik für Endokrinologie, Diabetologie und Klinische Ernährung, Universitätsspital Zürich, Zurich, Switzerland; Medizinische Klinik und Poliklinik III, University Hospital Carl Gustav Carus Dresden, Germany."
}
},
{
"@type": "Person",
"name": "Katja Kiseljak-Vassiliades",
"url": "https://questionsmedicales.fr/author/Katja%20Kiseljak-Vassiliades",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Sandra Sigala",
"url": "https://questionsmedicales.fr/author/Sandra%20Sigala",
"affiliation": {
"@type": "Organization",
"name": "Department of Molecular & Translational Medicine, Section of Pharmacology, University of Brescia, 25123 Brescia, Italy."
}
},
{
"@type": "Person",
"name": "Jaydira Del Rivero",
"url": "https://questionsmedicales.fr/author/Jaydira%20Del%20Rivero",
"affiliation": {
"@type": "Organization",
"name": "Developmental Therapeutics Branch, Rare Tumor Initiative, Center for Cancer Research, National Cancer Institute, Bethesda, MD, United States."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Designing and implementing a research integrity promotion plan: Recommendations for research funders.",
"datePublished": "2022-08-19",
"url": "https://questionsmedicales.fr/article/35984842",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1371/journal.pbio.3001773"
}
},
{
"@type": "ScholarlyArticle",
"name": "Study Types in Orthopaedics Research: Is My Study Design Appropriate for the Research Question?",
"datePublished": "2022-09-06",
"url": "https://questionsmedicales.fr/article/36162926",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.arth.2022.05.028"
}
},
{
"@type": "ScholarlyArticle",
"name": "Value of implementation science and hybrid implementation research designs for nursing education research: A discussion paper.",
"datePublished": "2023-04-25",
"url": "https://questionsmedicales.fr/article/37119757",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.nepr.2023.103650"
}
},
{
"@type": "ScholarlyArticle",
"name": "Research Methods Used in Evidence-Based Design: An Analysis of Five Years of Research Articles From the",
"datePublished": "2022-11-24",
"url": "https://questionsmedicales.fr/article/36424761",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1177/19375867221125940"
}
},
{
"@type": "ScholarlyArticle",
"name": "The Relative Merits of Observational and Experimental Research: Four Key Principles for Optimising Observational Research Designs.",
"datePublished": "2022-11-03",
"url": "https://questionsmedicales.fr/article/36364910",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/nu14214649"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Maladies endocriniennes",
"item": "https://questionsmedicales.fr/mesh/D004700"
},
{
"@type": "ListItem",
"position": 3,
"name": "Tumeurs des glandes endocrines",
"item": "https://questionsmedicales.fr/mesh/D004701"
},
{
"@type": "ListItem",
"position": 4,
"name": "Tumeurs de la surrénale",
"item": "https://questionsmedicales.fr/mesh/D000310"
},
{
"@type": "ListItem",
"position": 5,
"name": "Tumeurs corticosurrénaliennes",
"item": "https://questionsmedicales.fr/mesh/D000306"
},
{
"@type": "ListItem",
"position": 6,
"name": "Carcinome corticosurrénalien",
"item": "https://questionsmedicales.fr/mesh/D018268"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Carcinome corticosurrénalien - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Carcinome corticosurrénalien",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-14",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Carcinome corticosurrénalien",
"description": "Comment diagnostique-t-on un carcinome corticosurrénalien ?\nQuels tests hormonaux sont utilisés pour le diagnostic ?\nQuelle imagerie est la plus courante pour ce cancer ?\nLe diagnostic peut-il être confirmé par une biopsie ?\nQuels signes cliniques peuvent indiquer un carcinome corticosurrénalien ?",
"url": "https://questionsmedicales.fr/mesh/D018268?mesh_terms=Research+Design#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Carcinome corticosurrénalien",
"description": "Quels sont les symptômes courants du carcinome corticosurrénalien ?\nLe carcinome corticosurrénalien cause-t-il des problèmes hormonaux ?\nComment le carcinome corticosurrénalien affecte-t-il le métabolisme ?\nY a-t-il des symptômes spécifiques chez les femmes ?\nLe carcinome corticosurrénalien peut-il causer des douleurs ?",
"url": "https://questionsmedicales.fr/mesh/D018268?mesh_terms=Research+Design#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Carcinome corticosurrénalien",
"description": "Peut-on prévenir le carcinome corticosurrénalien ?\nQuels facteurs de risque sont associés à ce cancer ?\nLe mode de vie influence-t-il le risque de ce cancer ?\nLes examens réguliers aident-ils à la détection précoce ?\nY a-t-il des vaccins pour prévenir ce cancer ?",
"url": "https://questionsmedicales.fr/mesh/D018268?mesh_terms=Research+Design#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Carcinome corticosurrénalien",
"description": "Quels sont les traitements principaux pour ce cancer ?\nLa chirurgie est-elle toujours possible ?\nQuand la chimiothérapie est-elle recommandée ?\nLa radiothérapie est-elle efficace pour ce type de cancer ?\nY a-t-il des traitements ciblés disponibles ?",
"url": "https://questionsmedicales.fr/mesh/D018268?mesh_terms=Research+Design#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Carcinome corticosurrénalien",
"description": "Quelles sont les complications possibles du carcinome corticosurrénalien ?\nLe carcinome peut-il entraîner des problèmes cardiovasculaires ?\nComment les déséquilibres hormonaux affectent-ils la santé ?\nY a-t-il un risque accru de récidive après traitement ?\nLe carcinome corticosurrénalien peut-il affecter la qualité de vie ?",
"url": "https://questionsmedicales.fr/mesh/D018268?mesh_terms=Research+Design#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Carcinome corticosurrénalien",
"description": "Quels sont les principaux facteurs de risque du carcinome corticosurrénalien ?\nLes maladies génétiques augmentent-elles le risque ?\nL'âge est-il un facteur de risque ?\nLe sexe influence-t-il le risque de ce cancer ?\nLe stress a-t-il un impact sur le risque de carcinome ?",
"url": "https://questionsmedicales.fr/mesh/D018268?mesh_terms=Research+Design#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostique-t-on un carcinome corticosurrénalien ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'imagerie, les tests hormonaux et la biopsie."
}
},
{
"@type": "Question",
"name": "Quels tests hormonaux sont utilisés pour le diagnostic ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "On mesure les niveaux de cortisol, d'aldostérone et d'androgènes dans le sang."
}
},
{
"@type": "Question",
"name": "Quelle imagerie est la plus courante pour ce cancer ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "La tomodensitométrie (TDM) est souvent utilisée pour visualiser la tumeur."
}
},
{
"@type": "Question",
"name": "Le diagnostic peut-il être confirmé par une biopsie ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une biopsie permet de confirmer la présence de cellules cancéreuses."
}
},
{
"@type": "Question",
"name": "Quels signes cliniques peuvent indiquer un carcinome corticosurrénalien ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des signes comme l'hypertension, la perte de poids et des changements hormonaux peuvent apparaître."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants du carcinome corticosurrénalien ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent fatigue, hypertension, prise de poids et changements d'humeur."
}
},
{
"@type": "Question",
"name": "Le carcinome corticosurrénalien cause-t-il des problèmes hormonaux ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il peut entraîner un excès de cortisol, provoquant le syndrome de Cushing."
}
},
{
"@type": "Question",
"name": "Comment le carcinome corticosurrénalien affecte-t-il le métabolisme ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il peut provoquer une résistance à l'insuline et des troubles métaboliques."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes spécifiques chez les femmes ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les femmes peuvent présenter des signes d'hyperandrogénie, comme l'hirsutisme."
}
},
{
"@type": "Question",
"name": "Le carcinome corticosurrénalien peut-il causer des douleurs ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des douleurs abdominales ou lombaires peuvent survenir en raison de la tumeur."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir le carcinome corticosurrénalien ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de méthode de prévention spécifique, mais un suivi médical régulier est conseillé."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque sont associés à ce cancer ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antécédents familiaux et certaines maladies génétiques augmentent le risque."
}
},
{
"@type": "Question",
"name": "Le mode de vie influence-t-il le risque de ce cancer ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un mode de vie sain peut réduire le risque de nombreux cancers, y compris celui-ci."
}
},
{
"@type": "Question",
"name": "Les examens réguliers aident-ils à la détection précoce ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des examens réguliers peuvent aider à détecter des anomalies précoces."
}
},
{
"@type": "Question",
"name": "Y a-t-il des vaccins pour prévenir ce cancer ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Actuellement, il n'existe pas de vaccins spécifiques pour prévenir le carcinome corticosurrénalien."
}
},
{
"@type": "Question",
"name": "Quels sont les traitements principaux pour ce cancer ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement inclut la chirurgie, la chimiothérapie et la radiothérapie."
}
},
{
"@type": "Question",
"name": "La chirurgie est-elle toujours possible ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "La chirurgie est souvent la première option, mais dépend de l'étendue de la maladie."
}
},
{
"@type": "Question",
"name": "Quand la chimiothérapie est-elle recommandée ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle est souvent utilisée pour les cas avancés ou inopérables du carcinome."
}
},
{
"@type": "Question",
"name": "La radiothérapie est-elle efficace pour ce type de cancer ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle peut être utilisée pour réduire la taille de la tumeur ou traiter les métastases."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements ciblés disponibles ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des traitements ciblés sont en cours d'étude, mais ne sont pas encore standardisés."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles du carcinome corticosurrénalien ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent la propagation à d'autres organes et des déséquilibres hormonaux."
}
},
{
"@type": "Question",
"name": "Le carcinome peut-il entraîner des problèmes cardiovasculaires ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'hypertension et d'autres problèmes cardiovasculaires peuvent survenir."
}
},
{
"@type": "Question",
"name": "Comment les déséquilibres hormonaux affectent-ils la santé ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils peuvent provoquer des troubles métaboliques, des changements d'humeur et des problèmes de fertilité."
}
},
{
"@type": "Question",
"name": "Y a-t-il un risque accru de récidive après traitement ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le risque de récidive est élevé, nécessitant un suivi régulier après traitement."
}
},
{
"@type": "Question",
"name": "Le carcinome corticosurrénalien peut-il affecter la qualité de vie ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes et les traitements peuvent significativement impacter la qualité de vie."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque du carcinome corticosurrénalien ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antécédents familiaux, certaines maladies génétiques et l'obésité sont des facteurs de risque."
}
},
{
"@type": "Question",
"name": "Les maladies génétiques augmentent-elles le risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des syndromes comme le syndrome de Li-Fraumeni augmentent le risque de ce cancer."
}
},
{
"@type": "Question",
"name": "L'âge est-il un facteur de risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le carcinome corticosurrénalien est plus fréquent chez les adultes jeunes à moyens."
}
},
{
"@type": "Question",
"name": "Le sexe influence-t-il le risque de ce cancer ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les femmes sont légèrement plus susceptibles de développer ce cancer que les hommes."
}
},
{
"@type": "Question",
"name": "Le stress a-t-il un impact sur le risque de carcinome ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Bien que le stress soit un facteur de santé, son lien direct avec ce cancer n'est pas établi."
}
}
]
}
]
}
Division of Endocrinology and Diabetes, Department of Internal Medicine I, University Hospital, University of Würzburg, Würzburg, Germany; Comprehensive Cancer Mainfranken, University of Würzburg, Würzburg, Germany; Central Laboratory, University Hospital Würzburg, Würzburg, Germany.
Publications dans "Carcinome corticosurrénalien" :
Klinik für Endokrinologie, Diabetologie und Klinische Ernährung, Universitätsspital Zürich, Zurich, Switzerland; Medizinische Klinik und Poliklinik III, University Hospital Carl Gustav Carus Dresden, Germany.
Publications dans "Carcinome corticosurrénalien" :
Department of Endocrine Neoplasia and Hormonal Disorders, University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 1461, Houston, TX, 77030, USA. mahabra@mdanderson.org.
Publications dans "Carcinome corticosurrénalien" :
Division of Endocrinology and Diabetes, Department of Internal Medicine I, University Hospital, University of Würzburg, Würzburg, Germany; Comprehensive Cancer Mainfranken, University of Würzburg, Würzburg, Germany; Central Laboratory, University Hospital Würzburg, Würzburg, Germany.
Publications dans "Carcinome corticosurrénalien" :
Medical Oncology Unit, Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, University of Brescia, ASST Spedali Civili of Brescia, 25123 Brescia, Italy.
Publications dans "Carcinome corticosurrénalien" :
Division of Endocrinology and Diabetes, Department of Internal Medicine I, University Hospital, University of Würzburg, Würzburg, Germany. Electronic address: Altieri_B@ukw.de.
Publications dans "Carcinome corticosurrénalien" :
Division of Endocrinology and Diabetes, Department of Internal Medicine I, University Hospital, University of Würzburg, Würzburg, Germany; Institute of Metabolism and System Research, University of Birmingham, Birmingham, UK.
Publications dans "Carcinome corticosurrénalien" :
Instituto de Investigação e Inovação em Saúde (I3S), Universidade do Porto, Porto, Portugal.
Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP), Porto, Portugal.
Endocrine, Cardiovascular & Metabolic Research, Department of Anatomy, Multidisciplinary Unit for Biomedical Research (UMIB), Instituto de Ciências Biomédicas Abel Salazar, University of Porto (ICBAS/UP), Porto, Portugal.
Publications dans "Carcinome corticosurrénalien" :
Endocrine, Cardiovascular & Metabolic Research, Department of Anatomy, Multidisciplinary Unit for Biomedical Research (UMIB), Instituto de Ciências Biomédicas Abel Salazar, University of Porto (ICBAS/UP), Porto, Portugal.
Publications dans "Carcinome corticosurrénalien" :
Centre for Endocrinology, William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
Publications dans "Carcinome corticosurrénalien" :
Centre for Endocrinology, William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
Publications dans "Carcinome corticosurrénalien" :
Various stakeholders in science have put research integrity high on their agenda. Among them, research funders are prominently placed to foster research integrity by requiring that the organizations a...
When performing orthopaedic clinical research, alternative study designs can be more appropriate depending on the research question, availability of data, and feasibility. The most common observationa...
Nursing education research is complex and contextualized. The evaluation and impact of educational innovations on students, educators, and educational outcomes are influenced by the complexity of envi...
This paper aims to explore the value of implementation science theories, models, and frameworks and hybrid designs for interventional nursing education research and illustrate how these can be used in...
A brief overview of implementation science, the various types of theories, models and frameworks and Hybrid designs are provided. Illustrative examples demonstrating the incorporation of these methodo...
A brief overview of implementation and its key concepts namely context, implementation strategies, fidelity, outcomes, adaptation, and sustainability is provided. Three types of hybrid designs are dis...
The implications of implementation science for nursing education research are: a) Accelerating uptake of innovations to improve educational outcomes, b) targeting systematic change in individual and o...
Incorporating implementation science in nursing education research can optimize the uptake of educational innovations in practice in a sustainable manner. Nurse educators should equip themselves with ...
This study aims to analyze research methodologies from 157 research articles published in this journal in the last five years (2016-2020)....
Health environments research is comprised of research covering many topics and from various disciplines worldwide. No systematic study exists to uncover themes in evidence-based design (EBD) research ...
Case study research was used to analyze 157 articles published in the...
Findings are reported on categories commonly found in empirical research articles: (i) key words, (ii) disciplines from authors, (iii) settings studied, (iv) populations studied or sampled, (v) resear...
The analyses highlighted the research methods most frequently used in health environments research. Findings revealed several inconsistencies across articles on key words and the framing of research m...
The main barrier to the publication of observational research is a perceived inferiority to randomised designs with regard to the reliability of their conclusions. This commentary addresses this issue...
Hand surgeons are constantly faced with evaluation of new evidence to identify best practices in clinical care. However, even the most rigorous study designs have limitations due to biases, generaliza...
Health policy impacts all aspects of the authors' field. Research on this topic informs future policy direction and serves as an impactful means to advocate for their patients. The present work aims t...
Exercise as a subset of physical activity is a cornerstone in the management of multiple sclerosis (MS) based on its pleiotropic effects, but continued progression of the field requires better future ...
This paper outlines the work of the 'Study design and methodology' group of the MoXFo (moving exercise research forward) initiative, and addresses critical aspects and future directions when defining ...
The work is based on the formation of an international expert panel formed within the MoXFo initiative. We provide a structured and concise synthesis of exercise-specific MS research challenges and co...
Challenges and considerations are presented using the Patient population, Intervention, Comparator, Outcomes, Timing, Setting (PICOTS) framework, thereby forming a new and specific MS exercise PICOTS ...
We propose that researchers should carefully consider and align all elements of this MS exercise PICOTS framework when developing future research questions and study designs, ultimately improving the ...
Engaging with patients when designing a clinical or research project is beneficial; feedback from the intended audience provides invaluable insight form the patients' perspective. Working with patient...
Patients were included in the PREHABS study from inception to completion. The Theory of Change methodology was used to provide a framework to implement patient feedback to refine the study interventio...
In total, 69 patients engaged with the PREHABS project. Two patients were recruited as co-applicants on the grant and were members on the Trial Management Group. Six patients attended the pre applicat...
It is practicable and beneficial to include patients at all stages of designing and delivering a research study. Patient feedback can help refine the study interventions to allow for maximum acceptanc...
Including patients in the design of radiotherapy research studies can provide invaluable insight that can support the selection and delivery of interventions that are acceptable to the patient cohort....
Evidence-based medicine and evidence hierarchies have been widely adopted and have strongly influenced decision making across many fields, including clinical aphasiology. However, questions remain abo...
This article builds on ideas about scientific approaches and evidence originally shared by Elman (1995, 1998, 2006). This article reviews the history of evidence hierarchies and argues that improving ...
Concepts from a wide variety of fields including philosophy of science, research design and methodology, and precision medicine are brought together in an attempt to focus research on the scientific u...
It is hoped that by incorporating diverse research designs, methods, and perspectives, clinical aphasiologists will become better able to provide effective, personalized treatments, ensuring that each...